Velsecorat - AstraZeneca
Alternative Names: AZ 13189620; AZD-7594Latest Information Update: 05 Nov 2023
At a glance
- Originator AstraZeneca
- Class Amides; Antiasthmatics; Benzamides; Dioxanes; Fluorinated hydrocarbons; Indazoles; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Glucocorticoid receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 28 Jun 2021 Pharmacokinetics, pharmacodynamic and safety data of phase I (AMBER) study in Asthma presented at 117th International Conference of the American Thoracic Society
- 14 May 2021 Adverse events and efficacy data from a phase IIb GRANITE trial in Asthma presented at the 117th International Conference of the American Thoracic Society (ATS-2021)
- 14 May 2021 Pharmacodynamics data from a preclinical trial presented at the 117th International Conference of the American Thoracic Society (ATS-2021)